Interactive Strength Inc. (Nasdaq:TRNR) Expands CLMBR’s Presence with Military and College Accounts by Exhibiting at the Athletic Business Show on November 19-22

November 18, 2024 7:00 AM

Interactive Strength Inc. (NASDDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company will be exhibiting CLMBR to focus on Military and College/High School accounts at the Athletic Business Show on November 19-22 in New Orleans, Louisiana.Trent Ward, Co-Founder and CEO of TRNR, said: "The Athletic Business Show is the key annual event for buyers from...

Read more

Dosell Secures Large Order for 1,000 Units in the Netherlands - Order Value of SEK 3 Million and Up to SEK 400,000/Month in Recurring Revenue

November 18, 2024 3:20 AM

STOCKHOLM, SE / ACCESSWIRE / November 18, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ) ("iZafe") announces today that it has received a new confirmed order for an additional 1,000 Dosell units from its exclusive distributor in the Netherlands, TCCN. This strategically important order has a value of approximately SEK 3 million. Deliveries will be split into two batches - 750 units in 2024 and the remaining 250 in the first half of 2025...

Read more

UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial

November 18, 2024 2:00 AM

Nanomerics Ltd., a private speciality pharmaceutical company announced that it had received clinical trials authorisation for its first in human OC134 trial from the Medicinal and Healthcare Products Regulatory Agency (MHRA), the UK regulator.This means that the trial of OC134 in human subjects may now proceed. OC134 is an eye drop medicine candidate indicated for the topical treatment of, e.g., moderate to severe allergic conjunctivitis, a...

Read more

Hometown NP Expands Telepsychiatry Services to 39 States Nationwide

November 17, 2024 10:00 PM

FRANKFORT, IL / ACCESSWIRE / November 17, 2024 / Hometown NP, co-founded by Dr. Chime Ajiere, DNP, in 2023, is a leading telehealth practice specializing in telepsychiatric care. The organization is excited to announce that its services are now available in 39 states, reflecting a commitment to providing personalized and compassionate mental health support. Hometown NP addresses a wide range of conditions, including anxiety, depression, PTSD,...

Read more

Stars Shine at Beverly Hills Gala by Beauty-Stem: Advancing Health Innovations and Cancer Research

November 16, 2024 12:15 PM

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / Today, in the heart of Beverly Hills, Beauty-Stem-a branch of Power-Stem Biomedical-hosted a prestigious gala, bringing together prominent philanthropists and industry leaders in support of cutting-edge stem cell advancements and crucial cancer research alongside the American Cancer Society. High-profile guests like Kathryn Morris and Victoria Summer attended the event, which featured the...

Read more

Addressing Gender Equity and Women’s Empowerment in Underserved Communities

November 16, 2024 9:00 AM

Boston Female Leaders Support Whittier Street Health Center's Vulnerable and Underserved Women and FamiliesBOSTON, MA / ACCESSWIRE / November 16, 2024 / Whittier Street Health Center will bring together more than prominent women leaders in Greater Boston from diverse backgrounds for its annual Women for Whittier's Holiday Tea on Wednesday, Dec. 11, 2024, at the Frederica M. Williams Building in Roxbury, Massachusetts. The event, which will...

Read more

My Compounding Pharmacy Expands to Offer Veterinary Services Across Australia

November 15, 2024 6:30 PM

In a significant development for pet health, My Compounding Pharmacy, based in Sydney, Australia, has announced the expansion of its services to include bespoke veterinary compounding. Recognizing the challenges veterinarians face when prescribing medications for a diverse range of animal patients, this new service is designed to provide customized solutions for pets of all kinds across Australia.My Compounding Pharmacy understands the unique...

Read more

Accelerating Demand for Specialized RCM Solutions in Outpatient and Ancillary Services Set to Surge in 2025, Reports Black Book Research

November 15, 2024 4:30 PM

The U.S. healthcare revenue cycle management (RCM) outsourcing market for outpatient and ancillary services is experiencing significant growth. In 2023, the market sector was valued at approximately USD 6.1 billion. Projections indicate that it will reach USD 24.7 billion by 2030, reflecting a compound annual growth rate (CAGR) of 26.3% during the forecasted period.TAMPA, FL / ACCESSWIRE / November 15, 2024 / As the healthcare industry...

Read more

Veterans Bridge Home Receives 2024 HIRE Vets Medallion Award From the U.S. Department of Labor

November 15, 2024 2:00 PM

Charlotte-based nonprofit recognized for exceptional commitment to hiring and retaining veteransCHARLOTTE, NC / ACCESSWIRE / November 15, 2024 / Veterans Bridge Home (VBH), a leading non-profit organization dedicated to connecting, leading and advocating for veterans and their families across the Carolinas, has been selected for a 2024 HIRE Vets Platinum Medallion Award. This recognition, presented by the U.S. Department of Labor, honors VBH's...

Read more

THIRA Health Welcomes Patricia Charles-Heathers, Ph.D., MPA, as New Executive Director

November 15, 2024 12:00 PM

Seasoned Behavioral Health Leader Joins THIRA Health, Strengthening Commitment to Comprehensive Mental Health Care for Women and AdolescentsBELLEVUE, WA / ACCESSWIRE / November 15, 2024 / THIRA Health is pleased to announce the appointment of Patricia Charles-Heathers, Ph.D., MPA, as its new Executive Director. With over 30 years of experience in behavioral health, human services, and public administration, Dr. Charles-Heathers brings a wealth...

Read more

DuneGlass Capital Announces the Launch of Aviva Aesthetics: The Industry's Only Entrepreneur-Owned and Led Medical Aesthetics Platform

November 15, 2024 11:25 AM

CHICAGO, IL and FULTON, MD / ACCESSWIRE / November 15, 2024 / DuneGlass Capital, a healthcare services-focused independent sponsor that specializes in the formation of doctor and entrepreneur-owned and led management services organizations (MSOs), has partnered with Pura Vida Medspa & Cosmetic Laser Center, a leading medical spa in Fulton, Maryland, to form Aviva Aesthetics, the only aesthetics platform that is owned, led, and governed by med...

Read more

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

November 15, 2024 10:20 AM

Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands.Solid liquidity position, with cash and cash equivalents exceeding $3.3 million.Hard assets, mainly comprised of debt-free properties, valued at over $12 million; exceeding total debt and providing financing flexibility.Liquid inventory position and accounts receivable that are collected at an accelerated pace provide...

Read more

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results

November 15, 2024 9:10 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the third quarter 2024 ended September 30, 2024."Our team has made nothing short of transformational advancements throughout 2024. Fundamentally, the Company has never been stronger, and...

Read more

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

November 15, 2024 8:00 AM

BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today reported business updates and financial results for the three months ended September 30, 2024.Dr. Wei-Wu He, Chairman and CEO of CASI, said "The third quarter of 2024...

Read more

Justera Health Announces Management Change

November 15, 2024 7:30 AM

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce the changes to the leadership to the Company.The Company regrets to announce that effective November 15, 2024, Mr. Young Cho Lee has stepped down as Chief Executive Officer of the Company.In response to Mr. Lee's departure, the Company's Director, Mr. Joshua Herman has taken the vacancy of Chief Executive Officer position. Mr. Herman brings extensive...

Read more

Encision Reports Second Quarter Fiscal Year 2025 Results

November 15, 2024 7:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 second quarter that ended September 30, 2024.The Company posted quarterly product net revenue of $1.65 million and service net revenue of $101 thousand, or total net revenue of $1.75 million for a...

Read more

Theralase(R) Closes Non-Brokered Private Placement

November 15, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a non-brokered private placement offering...

Read more

NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID

November 15, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30, 2024 with the Securities and Exchange Commission (SEC) on Thursday, November 14, 2024. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000141057824001991/nnvc-20240930x10q.htm).We reported that, as of September 30, 2024, we had cash and cash...

Read more

Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR

November 15, 2024 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of new data at the American Association for Cancer Research (AACR) Special Conference in Cancer Research, Liquid Biopsy: From Discovery to Clinical Implementation, in San Diego, US from 13 to 16 November 2024.ANGLE is...

Read more

Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR

November 15, 2024 2:00 AM

RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCEParsortix-based HER2 kit being developed to provide an optimised, easily implemented, solution to enable product customers to undertake longitudinal, repeat assessment of HER2 status in breast cancerGUILDFORD, SURREY / ACCESSWIRE / November 15, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with...

Read more